Latest Period
Q1 2026
Security Snapshot
FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY) Institutional Ownership
CUSIP: 31447E105
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
36
Shares (Excl. Options)
9,472,339
Price
$0.42
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- FEMY on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 9,472,339
- Total 13F value
- $3,979,908
- Portfolio coverage rank
- 0%
- Share change
- -144,322
- Value change
- -$150,277
- Number of holders
- 36
- Shares outstanding
- 62,678,844
- SEC-reported price per share
- $0.45
- Insider filing price
- $0.45
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FEMY - FEMASYS INC - Common Stock, par value $0.0001 per share is tracked under CUSIP 31447E105.
- 36 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 37 to 36 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,032,737 to $3,979,908.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 36 institutions filings for Q1 2026.
Security key
31447E105
Latest holder period
Q1 2026
13F holders
36
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
FEMY full holder history
FEMASYS INC SEC filings
FEMASYS INC company facts
FEMASYS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 31447E105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
FEMY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | 7.9% | $2,762,382 | 4,932,825 | PharmaCyte Biotech, Inc. | 17 Mar 2026 | |||
| Alumni Capital LP | 10% | $3,866,599 | 4,773,579 | Alumni Capital LP | 04 Sep 2025 | |||
| Dauntless Investment Group, LLC | 9.9% | +90% | $1,549,149 | +$1,045,272 | 4,395,996 | +207% | Dauntless Investment Group, LLC | 30 Sep 2025 |
| Chernett Jorey | 9.3% | +52% | $2,930,561 | +$1,361,799 | 3,034,335 | +87% | Chernett Jorey | 30 Jun 2025 |
As of 31 Mar 2026, 36 institutional investors reported holding 9,472,339 shares of FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY). This represents 15% of the company’s total 62,678,844 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 9.6% | 6,033,030 | 0% | 7.1% | $2,535,079 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2% | 1,236,673 | 0% | 0% | $519,403 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 621,366 | +60% | 0% | $261,115 |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 249,876 | 0% | 0% | $104,948 |
| BlackRock, Inc. | 0.28% | 178,501 | +32% | 0% | $75,006 |
| NORTHERN TRUST CORP | 0.19% | 118,411 | +57% | 0% | $49,756 |
| Clear Creek Financial Management, LLC | 0.18% | 115,556 | +5.4% | 0% | $48,557 |
| EP Wealth Advisors, LLC | 0.16% | 100,000 | 0% | $42,020 | |
| XTX Topco Ltd | 0.15% | 94,142 | +327% | 0% | $39,558 |
| STATE STREET CORP | 0.13% | 80,869 | 0% | 0% | $33,981 |
| Virtu Financial LLC | 0.13% | 80,150 | 0% | $34,000 | |
| Kovack Advisors, Inc. | 0.11% | 70,000 | +50% | 0% | $29,414 |
| Cetera Investment Advisers | 0.1% | 62,000 | 0% | 0% | $26,052 |
| UBS Group AG | 0.1% | 61,929 | -32% | 0% | $26,010 |
| OSAIC HOLDINGS, INC. | 0.08% | 47,964 | +1.9% | 0% | $20,144 |
| NWF Advisory Services Inc. | 0.08% | 47,055 | 0% | 0% | $19,773 |
| JANE STREET GROUP, LLC | 0.05% | 32,276 | -70% | 0% | $13,562 |
| Wealthspire Advisors, LLC | 0.04% | 28,134 | 0% | 0% | $11,822 |
| HRT FINANCIAL LP | 0.04% | 26,738 | -49% | 0% | $11,000 |
| Aljian Capital Management, LLC | 0.04% | 25,268 | 0% | 0% | $10,618 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.03% | 20,000 | 0% | 0% | $8,404 |
| Bay Rivers Group | 0.03% | 19,000 | -43% | 0% | $7,984 |
| Mariner, LLC | 0.03% | 18,738 | 0% | 0% | $7,874 |
| WHITTIER TRUST CO OF NEVADA INC | 0.03% | 15,881 | 0% | 0% | $6,824 |
| CX Institutional | 0.02% | 15,000 | 0% | 0% | $6,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 9,472,339 | $3,979,908 | -$150,277 | $0.42 | 36 |
| 2025 Q4 | 3,527,637 | $2,032,737 | +$892,676 | $0.58 | 37 |
| 2025 Q3 | 3,739,959 | $1,316,955 | -$688,242 | $0.35 | 31 |
| 2025 Q2 | 2,806,752 | $2,709,104 | +$451,125 | $0.97 | 35 |
| 2025 Q1 | 3,903,741 | $4,879,295 | +$1,890,698 | $1.25 | 30 |
| 2024 Q4 | 2,385,879 | $2,624,495 | +$784,707 | $1.10 | 29 |
| 2024 Q3 | 1,672,303 | $1,856,384 | +$34,980 | $1.11 | 27 |
| 2024 Q2 | 1,639,679 | $1,868,650 | +$122,478 | $1.14 | 28 |
| 2024 Q1 | 1,521,808 | $2,358,654 | +$126,161 | $1.55 | 23 |
| 2023 Q4 | 1,476,749 | $1,440,174 | -$2,263,713 | $0.98 | 24 |
| 2023 Q3 | 1,648,910 | $5,724,136 | +$239,815 | $2.98 | 27 |
| 2023 Q2 | 1,189,769 | $3,176,795 | +$2,570,143 | $0.51 | 20 |
| 2023 Q1 | 1,189,709 | $1,263,455 | +$168,111 | $1.08 | 16 |
| 2022 Q4 | 987,996 | $889,424 | +$85,672 | $0.90 | 16 |
| 2022 Q3 | 884,106 | $999,000 | +$4,354 | $1.13 | 15 |
| 2022 Q2 | 821,662 | $1,979,647 | +$39,372 | $2.41 | 16 |
| 2022 Q1 | 817,819 | $1,847,000 | +$588,503 | $2.26 | 14 |
| 2021 Q4 | 515,082 | $2,008,000 | -$751,831 | $3.90 | 13 |
| 2021 Q3 | 522,946 | $3,605,000 | -$707,281 | $6.89 | 9 |
| 2021 Q2 | 601,218 | $4,904,864 | +$4,904,864 | $8.11 | 11 |